What is leukopenia
Pro Research Analysisby 
Searched over 200M research papers
Understanding Leukopenia: Causes, Diagnosis, and Management
What is Leukopenia?
Leukopenia is a medical condition characterized by an abnormally low number of white blood cells (WBCs) in the bloodstream, particularly granulocytes, which are a type of WBC1. This condition is often used interchangeably with neutropenia, which specifically refers to a reduction in neutrophils, the most abundant type of WBCs1 2. Neutrophils play a crucial role in fighting infections, and their deficiency can lead to an increased risk of infections1 2.
Causes of Leukopenia
Reduced Production and Increased Destruction
Leukopenia can result from either reduced production of WBCs or increased destruction and utilization of these cells, or a combination of both1. Common causes include infections, certain medications, malignancies, megaloblastosis (a type of anemia), hypersplenism (overactive spleen), and immunoneutropenia (immune-mediated destruction of neutrophils)1.
Intrinsic and Extrinsic Factors
Neutropenia, a subset of leukopenia, can be classified based on its duration as either transient or chronic. Chronic neutropenia can be further divided into intrinsic causes, such as impaired proliferation and maturation of myeloid progenitor cells in the bone marrow, and extrinsic causes, which are varied and numerous2.
Hereditary and Rare Causes
Primary neutropenia is rare and can sometimes be hereditary, particularly in children, where it may be associated with other developmental defects1. Familial Mediterranean Fever (FMF) is an example of a hereditary condition that can cause episodic and self-limited leukopenia due to autophagy and apoptosis processes5.
Diagnosis of Leukopenia
Clinical Assessment
The diagnosis of leukopenia involves a thorough history and physical examination to identify the underlying cause3. Selective laboratory tests, including complete blood counts and bone marrow biopsies when indicated, are essential in the diagnostic process3.
Severity and Duration
The assessment should consider the severity and duration of leukopenia, as well as the clinical status of the patient2. For instance, an absolute neutrophil count (ANC) of less than 1,500/mcL is indicative of neutropenia, and the risk of febrile neutropenia should be systematically assessed2.
Management of Leukopenia
Identifying the Cause
Effective management of leukopenia requires identifying and addressing the underlying cause1 2. For example, in cases of neutropenia with sepsis, empiric broad-spectrum antibiotic therapy must be initiated promptly while investigating the infectious agent3.
Antimicrobial Therapy
Patients with febrile neutropenia should receive antibiotics to prevent life-threatening bacterial infections2. The management strategy should be individualized based on the acuity, severity, age of the patient, and presence of infection3.
Special Considerations in Systemic Lupus Erythematosus (SLE)
In patients with systemic lupus erythematosus (SLE), leukopenia, lymphopenia, and neutropenia are prevalent and can increase the risk of major infections4. While the use of colony-stimulating factors (CSF) has been explored, the evidence is not robust enough to make specific recommendations, highlighting the need for further studies4.
Conclusion
Leukopenia is a complex condition with various causes and significant clinical implications, particularly the increased risk of infections. Accurate diagnosis and effective management require a comprehensive understanding of the underlying causes and tailored therapeutic approaches. Further research is needed to optimize treatment strategies, especially in specific patient populations such as those with SLE.
Sources and full results
Most relevant research papers on this topic
The etiology and management of leukopenia.
Leukopenia is caused by various factors, and effective management requires identification of the cause and effective antimicrobial therapy to prevent infection.
Hematologic Conditions: Leukopenia.
Leukopenia is a common hematologic condition, with treatment focusing on managing the underlying cause and preventing febrile neutropenia.
The evaluation and management of leukopenia
Leukopenia is often caused by benign conditions, but aggressive management is necessary in certain circumstances, such as neutropenia with sepsis.
Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review.
This systematic literature review is inconclusive on the prevalence and impact of leukopenia, lymphopenia, and neutropenia in SLE patients, and the safety of colony stimulating factors in treating leukopenia.
Systematic Review
Highly CitedLeukopenia in Familial Mediterranean Fever: Case Series and Literature Review with Special Emphasis on Pathogenesis
Familial Mediterranean fever (FMF) can cause leukopenia, with autophagy and apoptosis processes mainly explaining the specific (episodic and self-limited) leukopenia in this disorder.
Case ReportHemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
Dialyzer cellophane membranes activate complement, leading to granulocyte and monocyte entrapment in the pulmonary vasculature during the first hour of hemodialysis.
Highly CitedElucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.
Sanguisorba Officinalis L.'s molecular mechanism against leukopenia involves enhancing peripheral white blood cell production through PI3K-Akt, HIF-1, VEGF, and estrogen signaling pathways.
In Vitro Study
Rigorous JournalVery small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions.
VSSP-based vaccines can effectively stimulate cytotoxic T lymphocyte responses in leukopenic mice, potentially benefiting active immunotherapy strategies in severe immune compromised scenarios.
Non-RCT
Animal StudyThe Efficacy and Safety of Diyushengbai Tablet on Preventing and Treating Leukopenia Caused by Radiotherapy and Chemotherapy Against Tumor: A Systematic Review and Meta-Analysis
Diyushengbai tablet (DYT) is more effective in preventing and treating leukopenia caused by radiotherapy and chemotherapy than other oral WBC-elevating drugs, potentially reducing the need for additional G-CSF application.
Meta-Analysis